- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Patent holdings for IPC class A61K 35/742
Total number of patents in this class: 1391
10-year publication summary
|
92
|
103
|
96
|
148
|
149
|
152
|
145
|
144
|
153
|
96
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Seres Therapeutics, Inc. | 83 |
33 |
| The University of Tokyo | 4208 |
33 |
| Finch Therapeutics Holdings, LLC | 74 |
31 |
| Novozymes A/S | 3333 |
27 |
| Evonik Operations GmbH | 4166 |
25 |
| Vedanta Biosciences, Inc. | 58 |
22 |
| Sami Labs Limited | 105 |
21 |
| Native Microbials, Inc. | 63 |
20 |
| Société des Produits Nestlé S.A. | 9322 |
19 |
| Microbial Discovery Group, LLC | 69 |
19 |
| The Regents of the University of California | 20087 |
18 |
| Pendulum Therapeutics, Inc. | 43 |
16 |
| Church & Dwight Co., Inc. | 1887 |
14 |
| NCH Corporation | 252 |
14 |
| School Corporation, Azabu Veterinary Medicine Educational Institution | 56 |
14 |
| Seed Health, Inc. | 161 |
12 |
| Ferring Microbiome Inc. | 42 |
12 |
| Ganeden Biotech, Inc. | 55 |
11 |
| Chr. Hansen A/S | 1065 |
10 |
| International N&h Denmark ApS | 343 |
10 |
| Other owners | 1010 |